{"id":157275,"date":"2025-07-17T04:19:54","date_gmt":"2025-07-17T04:19:54","guid":{"rendered":"https:\/\/quixnet.net\/wpinstance\/world-leaders-recommit-to-immunisation-amid-global-funding-shortfall-gavi-the-vaccine-alliance\/"},"modified":"2025-07-17T04:19:54","modified_gmt":"2025-07-17T04:19:54","slug":"world-leaders-recommit-to-immunisation-amid-global-funding-shortfall-gavi-the-vaccine-alliance","status":"publish","type":"post","link":"https:\/\/quixnet.net\/wpinstance\/world-leaders-recommit-to-immunisation-amid-global-funding-shortfall-gavi-the-vaccine-alliance\/","title":{"rendered":"World leaders recommit to immunisation amid global funding shortfall – Gavi, the Vaccine Alliance"},"content":{"rendered":"

Contact us<\/a> ISO certification<\/a> Phishing & fraud<\/a>
Contact us<\/a> ISO certification<\/a> Phishing & fraud<\/a>
About Gavi<\/a> Facts & figures<\/a> Contact us<\/a>
About Gavi<\/a> Facts & figures<\/a> Contact us<\/a>
Strategic finance<\/strong><\/big>
\"Innovative<\/a>
As part of our long-term funding and private sector engagement strategy, we use innovative finance mechanisms to incentivise investment in immunisation.
Learn more<\/a>
Key publication<\/strong><\/big><\/p>\n

Gavi’s Investment Opportunity <\/strong>
2026\u20132030<\/strong>
Download<\/a>
Global Summit, 25 June 2025<\/a>
Global Summit, 25 June 2025<\/a>
 
VaccinesWork is an award-winning digital platform hosted by Gavi, the Vaccine Alliance covering news, features and explainers from every corner of global health and immunisation.<\/big>
About<\/a> | Homepage<\/a>
Latest VaccinesWork<\/a> About VaccinesWork<\/a> Contact the Editor<\/a>
Latest VaccinesWork<\/a> About VaccinesWork<\/a> Contact the Editor<\/a>
Latest insights<\/strong><\/big>
\"Polio<\/a>
How we fight disease outbreaks: first-hand accounts from the epidemic frontlines<\/strong>
Learn more<\/a>
News releases<\/strong><\/big><\/p>\n

View all our news releases to read the latest announcements<\/strong>
View news releases<\/a>
About Gavi<\/a> Facts & figures<\/a> Contact us<\/a>
About Gavi<\/a> Facts & figures<\/a> Contact us<\/a>
<\/a>
Brussels, 25 June 2025 <\/strong>\u2013 Today, at the Global Summit: Health and Prosperity through Immunisation<\/em><\/a> in Brussels, world leaders pledged support for Gavi, the Vaccine Alliance, leading to a total of more than US$ 9 billion secured against a targeted US$ 11.9 billion budget for its next five-year strategic period from 2026 to 2030 (Gavi 6.0)<\/a>. Additional donor commitments are expected in the coming months.
The Summit also resulted in US$ 4.5 billion in complementary financing unlocked from development finance institutions, up to US$ 200 million in cost savings for Gavi-supported programmes announced by vaccine manufacturers \u2013 alongside other innovation and supply commitments that will further boost equitable access to critical vaccines, and a range of private sector partnerships aimed at transforming immunisation systems in lower-income countries \u2013 including a US$ 40 million anchor commitment towards a new Innovation Scale-Up Fund.
Today\u2019s commitments bring Gavi a major step closer to securing the resources it needs for Gavi 6.0, in which it hopes to protect 500 million children from preventable disease, averting between 8-9 million future deaths, protecting the world from deadly outbreaks of diseases such as cholera, mpox and Ebola through its vaccine stockpiles and unlocking US$ 100 billion in economic benefits for countries.
The Summit, co-hosted by the European Union, Gates Foundation, and Gavi, in partnership with Global Citizen, was attended by representatives of 55 donor and implementing countries \u2013 including 10 heads of state and government and 24 ministers \u2013 as well as leaders from multilateral institutions, civil society, private sector and vaccine industry. Co-hosts the European Union and the Gates Foundation reaffirmed their leadership in global health by making strong commitments to Gavi. The Gates Foundation announced<\/a> a commitment of US$ 1.6 billion, underscoring its enduring partnership in Gavi\u2019s efforts to ensure child survival. The European Commission pledged EUR 360 million, as part of a total pledge of more than EUR 2 billion from Team Europe \u2013 which includes the EU and its Member States \u2013 collectively the largest donor to Gavi. At the Summit, the European Investment Bank (EIB) announced an extension of its EUR 1 billion liquidity facility that can be accessed by any donor to facilitate their pledge, while Team Europe has already pledged nearly EUR 800 million for Gavi\u2019s African Vaccine Manufacturing Accelerator (AVMA) to support local vaccine manufacturing.
In addition to the co-hosts, the Summit saw a record number of new donors step forward to support Gavi\u2019s next strategic cycle (2026\u20132030). With some of Gavi\u2019s existing donors unable to announce commitments due to a need to align pledging with their own domestic budgetary cycles, this broad base of support will provide critical momentum for Gavi as it continues to mobilise resources in pursuit of its US$ 11.9 billion fundraising target.*
With Gavi\u2019s implementing countries expected to invest a record US$ 4 billion towards their immunisation programmes over the coming five years, the Summit had strong representation from leaders pledging support and political commitment towards Gavi\u2019s model of sustainable co-financing and secure supply through a diversified manufacturing base, including increased manufacturing capacity in Africa. The Summit also saw enthusiastic engagement in discussions on reform of the global health architecture. Gavi, which is implementing its own transformative reform programme called the Gavi Leap, has offered to play a lead role in shaping a dialogue on how to evolve the current landscape so that it better serves countries, and to take proactive steps in forging closer collaboration with its partner agencies.
Leaders from all co-hosts of the Summit urged existing donors unable to pledge today as well as potential new donors to step forward to help Gavi reach its target of US$ 11.9 billion. Failure to fully fund Gavi will have significant consequences on the health and well-being of children in lower-income countries, as well as on global health security.
Ursula von der Leyen, President of the European Commission <\/strong>said: <\/strong>“Investing in health is investing in our shared future. Our work with Gavi saves lives. For over 20 years, we have stood side by side, with the European Union contributing over EUR 3.2 billion to vaccinate more than 1 billion children against deadly diseases. But millions still need this vital protection. Today, Team Europe is pledging more than EUR 2 billion. The EU remains committed to this mission so that children across the world are safer, healthier and stronger. This is global solidarity in action.\u201d
Ant\u00f3nio Costa, President of the European Council <\/strong>said: <\/strong>\u201cToday\u2019s summit is a powerful reminder that global health security is a shared responsibility. Immunisation is one of its strongest foundations. We have to ensure that every person, everywhere, has access to vaccines. The European Union is proud to stand at the forefront of this global effort, helping raise resources and forging innovative partnerships that will save lives, protect communities and promote prosperity. Through Gavi, we are investing not just in vaccines, but in the preparedness and resilience of health systems worldwide. Together with our partners, we are building a more secure and equitable global health architecture. The EU remains firm in its commitment to leaving no one behind.\u201d
Bill Gates, chair of the Gates Foundation <\/strong>said: \u201cIn a constrained budget environment, it\u2019s even more important to focus aid funding on the investments that really work. And Gavi is exactly that. I don\u2019t know of anything with a higher impact per dollar in terms of saving and improving lives. Gavi is one of the best investments I\u2019ve ever made \u2013 and one of the best investments countries can make today in the world\u2019s future.\u201d
Jos\u00e9 Manuel Barroso, Board Chair, Gavi <\/strong>said: \u201cToday is a good day for immunisation and a good day for global health. We have made impressive progress towards fully funding our next strategic period, secured vital access to finance for health systems investment and seen important progress that will shape vaccine markets and revolutionize last-mile delivery. I want to thank all our donors and stakeholders that have stepped up to pledge towards a successful Gavi 2026\u20132030 period.\u201d
Dr Sania Nishtar, CEO, Gavi <\/strong>said: \u201cI have been humbled by the support shown to Gavi today. As Gavi enters a new strategic period, a period which will see radical change to the way we support countries and converge with our partners at the last mile, we can do so with the confidence that not only our donors, but Gavi countries, the private sector and all other stakeholders stand with us as we build a healthier, more prosperous future.”
Unprecedented commitment from traditional and new donors, and Gavi-implementing countries<\/strong>
Alongside strong leadership from Gavi\u2019s traditional donors, the Summit welcomed a new generation of partners, resulting in commitments from the largest number of sovereign, philanthropic and private sector donors in Gavi\u2019s history. This includes former and current Gavi-supported countries Central African Republic, India, Indonesia, Rwanda and Uganda who all pledged to Gavi 6.0. Gavi implementing countries also emphasised their strong commitment to Gavi\u2019s co-financing model.
More than US$ 4.5 billion in new financial instruments and partnerships were announced at the Summit. This includes US$ 3 billion in partnerships with multilateral development banks to provide countries with flexible, long-term support as they transition from aid to self-sustained financing. Gavi will explore the development of a new MDB multiplier mechanism to increase the targeting and impact of joint investments with MDBs. A further US$ 1.5 billion was committed to provide additional liquidity to Gavi \u2013 leveraged against existing donor pledges \u2013 should it need rapid and flexible access to capital in the event of unexpected activities, including major outbreak or health emergency.
Commitments made by development finance institutions include:<\/em>
As a public-private partnership, Gavi was able to secure bold commitments from some of the world\u2019s most important vaccine manufacturers at today\u2019s Summit, who announced initiatives to improve access to critical vaccines against diseases like cervical cancer, Ebola, malaria, meningitis, pneumonia and rotavirus. In addition, price reductions, made possible by manufacturers passing on lower input costs, could enable savings for Gavi-supported programmes of up to US$ 200 million by 2030.
Commitments made by manufacturers include:<\/em>
The Summit also reaffirmed support to Africa\u2019s vaccine sovereignty through Gavi\u2019s African Vaccine Manufacturing Accelerator (AVMA), which will provide milestone-based financing to regional manufacturing and catalyse productive investment across the continent. AVMA is already driving impact, with technology transfer agreements underway across the continent.
Commitments announced at the Summit include:<\/em>
Today Gavi also welcomed an anchor US$ 40 million investment in a new Innovation Scale Up Fund, designed to fast-track innovative delivery solutions. Including this groundbreaking initiative, new private sector partnerships worth over US$ 149 million were announced, including collaborations to improve digital and supply chains.
Commitments made by the private sector include:<\/em>
H.E. Professor Faustin Archange Touadera, President of the Central African Republic: <\/strong>“It is with a sense of fulfilling a meaningful duty, imbued with solemnity, that I speak today on behalf of the Central African people to express our deep gratitude to Gavi, the Vaccine Alliance, and to solemnly reaffirm our shared commitment to universal vaccination. I also speak today not only as the President of the Central African Republic, but also as a representative of the millions of African children who depend on our support for their development and their future. The Central African Republic firmly and faithfully advocates for an ambitious and sustainable mobilisation of resources in support of GAVI for the next five years. In this spirit, I am pleased to announce that the Central African Republic is committing to contribute US$ 1 million over the next five years.”
H.E. John Mahama, President, Ghana<\/strong>: \u201cIn Ghana, we do not view immunisation as a privilege. It is a right that protects our children, strengthens our public health systems, and propels us toward Universal Health Coverage and the broader goals of sustainable development. Vaccines have saved lives, transformed communities, and brought dignity and security to families across the nation. Our partnership with Gavi has been central to this success. Together, we have built a resilient, equitable immunisation system \u2013 one that has evolved from reactive emergency response to a fully integrated pillar of our public health infrastructure. As the global vaccine ecosystem evolves, Africa must take charge of its future. Ghana fully endorses the African Union\u2019s goal of producing 60% of the continent\u2019s vaccine needs by 2040. Our vaccine manufacturing must focus on vaccines for diseases prevalent in our region. For us, vaccine production is not just an ambition \u2013 it is a strategic imperative and a matter of national security.”
H.E. Kyriakos Mitsotakis, Prime Minister of the Hellenic Republic: <\/strong>\u201cGreece reaffirms its strong support for Gavi and its vital mission in promoting equitable access to life-saving vaccines. In a time of global challenges, Gavi embodies the power of multilateralism to deliver concrete results, strengthen health systems, and protect the most vulnerable \u2013 especially children \u2013 around the world, so that no one is left behind.\u201d
H.E. Miche\u00e1l Martin, Taoiseach, Ireland<\/strong>: \u201cVaccines have utterly transformed health outcomes across the world. Evidence from the World Health Organisation shows that vaccination is one of the best health investments that money can buy and one of the most impactful tools that we have available to us. Ireland is therefore proud to increase its support to the vital work of Gavi, the Vaccine Alliance, which is keeping people across the globe healthy and safe.\u201d
H.E. Robert Abela, Prime Minister of Malta<\/strong>: \u201cGavi plays a vital role in global vaccine distribution and in strengthening health systems worldwide. Malta remains firmly committed to supporting Gavi\u2019s core mission. We will continue to be an active and engaged partner, both through our financial contribution to Gavi\u2019s 2026\u20132030 Investment Opportunity and by leveraging international fora \u2013 including the European Union and the United Nations \u2013 to advocate for equitable access to vaccines and the fundamental right to health for all.\u201d
H.E. Lu\u00eds Montenegro, Prime Minister of Portugal:<\/strong> \u201cOur cooperation with Gavi represents not only a shared investment in public health, but also a powerful expression of global solidarity. We will remain committed to this effort, and we commend all those who are also joining us in this common endeavour.\u201d
Hon. Julius Bio, President, Sierra Leone<\/strong>: \u201cOver the years, Sierra Leone has expanded access to life-saving vaccines, introduced the malaria vaccine, and rolled out the human papillomavirus vaccine for girls. With support from Gavi and partners, we have also prioritized epidemic preparedness through preventive vaccines against deadly diseases like Ebola and mpox \u2013 protecting our people and ensuring global health security. Today, we consistently maintain over 90% coverage of key childhood vaccines \u2013 among the highest in our region. These gains have contributed to real progress: child mortality has dropped by more than half, and our communities are healthier and more resilient. Even as traditional aid shifts, Sierra Leone remains committed to strengthening its immunisation programme. Because no nation, no matter how committed, can do this alone.\u201d
H.E. Pedro S\u00e1nchez, President of the Government of Spain:<\/strong> \u201cSpain\u2019s commitment to the multilateral system and, in particular, to the global health system, is absolute.\u201d
H.E. Amb. Amma A. Twum-Amoah, Commissioner for Health, Humanitarian Affairs and Social Development, African Union Commission: \u201c<\/strong>Africa\u2019s vision for the future is clear: a continent where no child dies for lack of a vaccine; where zero-dose children are not just reached but retained; where vaccine equity is driven not by global charity, but by local capacity, leadership and innovation. Gavi\u2019s 2026\u20132030 strategy aligns well with this vision. Let us invest \u2013 together \u2013 in a future defined by health, dignity and opportunity for every African child.\u201d
Hon. Dr Anne Aly MP, Minister for International Development, Australia<\/strong>: \u201cDuring these turbulent times, Australia is steadfast in our commitment to Gavi. We stand by Gavi because we know countries in our region and around the world rely on Gavi\u2019s support.\u201d
Hon. Dr. Jaleela bint Alsayed Jawad Hasan, Minister of Health, Kingdom of Bahrain<\/strong>: \u201cThe Global Summit has reaffirmed the transformative power of international solidarity in advancing equitable access to immunization as a cornerstone of health, stability, and sustainable development. The Kingdom of Bahrain stands alongside its partners in renewing our shared aspiration for a world where every individual can benefit from life-saving vaccines and the opportunities they bring for a healthier, more resilient future.\u201d
Hon. Randeep Sarai, Secretary of State (International Development), Canada: <\/strong>\u201cTackling global health challenges requires strong, united action. No child should suffer or die from a disease we can prevent. Canada\u2019s continued support to Gavi reflects our belief in the power of global partnerships to drive progress, protect the most vulnerable, and build a healthier, more equitable world for everyone.\u201d
Hon. Dr Abdel-Majid Abderahim Mahamat, Minister of Health, Chad<\/strong>: \u201cChad is facing extreme fragility, exacerbated by the effects of climate change, internal displacement, the massive arrival of refugees, and major logistical challenges. We have nonetheless, been able to make significant progress in our vaccination programme and for this, I would like to commend Gavi for its strategic support over the years, its swift response at the onset of the Sudan crisis, its support for refugees, as well as its investments in cold chain infrastructure and the overall strengthening of our vaccination system.”
Hon. Pierre N’gou Dimba, Minister of Health, Public Hygiene and Universal Health Coverage, C\u00f4te d\u2019Ivoire:<\/strong> \u201cC\u00f4te d\u2019Ivoire is pleased to announce a contribution of USD 100 million to Gavi\u2019s 2026\u20132030 strategy, marking its commitment to the Gavi model of co-financing and the importance of country ownership in protecting the next generation.\u201d
Hon. Dr Mekdes Daba, Minister of Health, Federal Democratic Republic of Ethiopia: <\/strong>“Immunisation is one of the most cost-effective interventions to protect children and communities from preventable diseases. Gavi\u2019s support has been instrumental in reaching those most in need as well as strengthening African countries\u2019 health systems. Continued investment in Gavi ensures equitable access to vaccines and safeguards global health.”
Hon. Yannick Neuder, Minister of Health, France: <\/strong>\u201cThe journey doesn\u2019t end today in Brussels. In the face of challenging budgetary and political contexts, it will continue to be a long one. But the COVID-19 crisis showed us that we are capable of rising to the greatest challenges together. And it is together that we will continue to go further, and faster!\u201d
Excellency Federal Minister for Economic Cooperation and Development Reem Alabali Radovan, Germany: <\/strong>\u201cGermany will stay committed to protecting people worldwide from diseases. This requires strong international partnerships like Gavi. Every euro we spend on prevention today saves many more in future treatments or pandemic responses.\u201d
Hon. JP Nadda, Minister of Health and Family Welfare, India<\/strong>: \u201cIndia\u2019s robust vaccine manufacturing capacity, which contributes to 60% of the global vaccine supply, has enabled Gavi to immunise more children within the same financial envelope. India pledges to support Gavi 6.0 strategic cycle 2026\u20132030, and we take this opportunity to announce our financial contribution of US$20 million to Gavi, echoing the vision of our Honourable Prime Minister Shri Narendra Modi for fulfilling India\u2019s role as Vishwa Bandhu, a trusted partner to the world.\u201d
Hon. Budi Gunadi Sadikin, Minister of Health, Indonesia:<\/strong> \u201cIndonesia’s partnership with Gavi over the past two decades has not only transformed our immunisation programmes but also reinforced the importance of global solidarity in health. By becoming a Gavi donor, we aim to ensure that every child, no matter where they live, can access life-saving vaccines. Indonesia’s pledge of US$ 30 million for Gavi 6.0 reflects our commitment to a healthier and more equitable world for future generations.\u201d
Hon. Antonio Tajani, Deputy Prime Minister and Minister of Foreign Affairs and International Cooperation, Italy<\/strong>: \u201cI am pleased to announce an Italian contribution of 250 million euros for the next funding cycle of Gavi. We want to keep working together \u2013 with vision and determination \u2013 to ensure that the right to health is a concrete reality for all\u201d.
H.E. Hisashi Matsumoto, Parliamentary Vice-Minister for Foreign Affairs, Japan<\/strong>: \u201cFor 25 years since its establishment, Gavi has overcome numerous challenges, including the COVID-19 pandemic. Gavi has made extraordinary contributions to UHC by ensuring equitable access to vaccines. Immunization saves countless lives and leads to economic growth and health security. Japan hereby promises to firmly and continuously support Gavi’s mission “Leaving no one behind with immunization.\u201d
H.E. Ki-hwan Kweon, Deputy Minister for Multilateral and Global Affairs, Republic of Korea<\/strong>: \u201cIn support of Gavi\u2019s life-saving missions, the Republic of Korea will make an initial contribution of 50 million US dollars to Gavi 6.0 strategic period. Looking ahead, we remain committed to working with Gavi, and will continue to engage in global partnerships for a healthier, safer and more secure future.\u201d
Hon. Xavier Bettel, Deputy Prime Minister, Minister for Foreign Affairs and Foreign Trade and Minister for Development Cooperation and Humanitarian Affair, Luxembourg<\/strong>: “I would like to underline Luxembourg\u2019s political and financial support to Gavi, our long term multilateral partner. Global health is a global public good and a priority for our development cooperation and humanitarian action strategy. Vaccine equity begins with access and access begins with capacity.”
Hon. Isabelle Rosabrunetto, Director General of the Ministry of Foreign Affairs and Cooperation, Monaco: <\/strong>“We must urgently accelerate our efforts to achieve target 3.2 of SDG 3. That is why the Principality of Monaco has decided to double its support to Gavi, the Vaccine Alliance, in order to help implement its 2026\u20132030 strategy.”
Hon. Professor Muhammad Ali Pate, Coordinating Minister of Health and Social Welfare, Federal Republic of Nigeria<\/strong>: “Nigeria supports Gavi’s replenishment because our partnership with Gavi has expanded access to the miracle of vaccines to millions of children. We will continue to increase our domestic resources for health and unlock our healthcare value chain with a view to transition over time.\u201d
Hon. Dr. Sabin Nsanzimana, Minister of Health, Rwanda<\/strong>: \u201cRwanda reaffirms our commitment to vaccines as one of the most impactful tools to prevent diseases, to end outbreaks,and to save lives. On behalf of his excellence, President Paul Kagame and the government of Rwanda, we pledge to support this replenishment with 1 million US dollars over the next five years.\u201d
Hon Ibrahima SY, Minister of Health and Social Action, Senegal<\/strong>: “For our countries, immunisation is a driver of human development and economic productivity. We must therefore eliminate zero-dose children by 2035.”
Hon. David Lammy, Foreign Secretary, United Kingdom<\/strong>: \u201cGavi\u2019s global impact is undeniable. Over 1 billion children vaccinated, over 18 million lives saved, over US$ 250 billion injected into the global economy. I\u2019m immensely proud of the role the UK has played in reaching these milestones. Our ongoing partnership with Gavi will give millions of children a better start, save lives and protect us all from the spread of deadly diseases.\u201d
Dr Jean Kaseya, Director General, Africa Centres for Disease Control and Prevention: \u201c<\/strong>Africa continues to bear the brunt of vaccine-preventable diseases, yet we are stepping up with innovation, resilience, and vision, expanding local manufacturing, reaching zero-dose children, and responding swiftly to outbreaks like Mpox and cholera. Gavi has been instrumental in this progress. We commend the European Union and the Gates Foundation for mobilising global support at a time when investments in health systems and epidemic preparedness are more urgent than ever. Gavi 6.0 represents a vital commitment to building health sovereignty and saving lives across our continent.\u201d
UNICEF Executive Director Catherine Russell: <\/strong>“We are deeply grateful to all those who pledged support for Gavi\u2019s next chapter. These commitments bring us closer to reaching half a billion children and expanding access to lifesaving vaccines. As the largest vaccine delivery and procurement agency, UNICEF brings the reach, experience, and determination to help turn this ambition into reality. But the work is far from over. Continued commitment and investment will be essential. Let us seize this moment \u2013 together \u2013 to make it real.\u201d
Dr Tedros Adhanom Ghebreyesus, WHO Director-General<\/strong>: \u201cThe world has moved closer to achieving immunization for all thanks to Gavi, the Vaccine Alliance. Gavi’s unwavering commitment to reaching children in the world\u2019s poorest countries has expanded protection against more diseases, saved millions of lives, and advanced vaccine equity, especially for children who have never received a single dose. Today’s commitments bring us one step closer to a world where everyone is protected against vaccine-preventable diseases.\u201d
Dr Chitkala Kalidas, Executive Director, Bayer Foundation:<\/strong> \u201cBuilding on our history of successful efforts to improve vaccination uptake and access to healthcare with partners like Gavi, Bayer Foundation is excited to be scaling and diversifying our collaboration in new and innovative ways, driving better health outcomes for coffee and cocoa smallholder farming communities across Africa.\u201d
Dr Krishna Ella, CEO, Bharat Biotech International Limited:<\/strong> \u201cBharat Biotech, a leader in novel and innovative vaccines, focuses on infectious diseases in Lower and Middle-Income Countries. It is proud to announce supplies of innovative vaccines for malaria and cholera during the GAVI 6.0 period. Bharat Biotech will manufacture at scale the world\u2019s first malaria vaccine, RTS,S\/AS01E, through a technology transfer partnership with GSK. RTS,S was developed in collaboration between GSK, PATH, and WHO. To address the critical shortage of Oral Cholera Vaccine (OCV), Bharat Biotech in partnership with MSD, Wellcome and Hilleman Laboratories aims to supply HILLCHOL\u00ae to support outbreak response, preventive vaccination campaigns, and stockpile replenishment across cholera-endemic and underserved regions.\u201d
H.R.H. the Infanta Cristina, Director of the International Area at the \u201cla Caixa\u201d Foundation: <\/strong>\u201cAs we look to the future, we carry with us not only the achievements of the past, but the conviction that even greater impact lies ahead. Behind every donation is a child whose life has been changed, and behind every company, every partner, there is someone who chose to believe in something bigger than themselves. This Alliance has proven that when purpose meets partnership, we can achieve the extraordinary.\u201d
Anna Hakobyan, Chief Impact Officer & Executive Director Nutrition, CIFF:<\/strong> \u201cIntegrated models of health and nutrition delivery \u2013 backed by real-time data and digital solutions \u2013 can offer pathways for scaling lifesaving interventions, including vaccines, therapeutic food and supplements in challenging contexts in more efficient and sustainable ways. We are proud to stand alongside partners who are reimagining what\u2019s possible for vulnerable children and families facing intersecting crises.\u201d
Rajinder Suri, CEO, Developing Countries Vaccine Manufacturers Network (DCVMN)<\/strong>: \u201cAs Gavi’s largest and most consistent vaccine partners, DCVMN members have delivered more than 4.9 billion doses to Gavi 5.0. This translates to over 40 products addressing 19 of Gavi\u2019s 20 target diseases \u2013 acting as sole suppliers for 12 of these diseases to ensure crucial accessibility, availability, and affordability. We remain steadfastly committed to Gavi\u2019s 6.0 strategy. Amidst current geopolitical challenges, we urge all donors, governments, and foundations to redouble their efforts to secure full funding for Gavi, thereby enabling it to sustain and expand equitable Health & Prosperity through Immunisation!\u201d
Nadia Calvi\u00f1o, President of the European Investment Bank<\/strong>: \u201cInvesting in health is investing in secure, stable and prosperous communities. The extension of the EIB’s EUR 1 billion financing package will maximise the impact of GAVI’s vaccination programmes in the poorest countries, protecting children and guarding against potential pandemic outbreaks. When we work together, we protect more lives \u2013 everywhere.\u201d
Dr Karlee Silver, CEO, Grand Challenges Canada: <\/strong>\u201cAs a seasoned impact-first investor of global health innovation, expanding equitable access to life-saving products and services is at the core of our work. We’re excited and energized to partner with Gavi to strengthen health systems and expand access to care by accelerating the scale of innovative solutions.\u201d
Thomas Breuer, Chief Global Health Officer, GSK: <\/strong>\u201cGSK has been a proud partner to Gavi since its inception, and together we\u2019ve helped protect millions of children. With over 1.2 billion vaccine doses supplied since 2010, including nearly 100 million in 2024 alone, we\u2019re committed to delivering health impact at scale through our scientific innovation. Our investment in Global Health R&D of \u00a31 billion over 10 years and recent improvements in manufacturing efficiencies and production capacity for our Gavi vaccines, enables us to contribute up to \u20ac100 million to Gavi 6.0, helping to get ahead of disease together.\u201d
Dr David Reddy, Director General, International Federation of Pharmaceutical Manufacturers and Associations (IFPMA)<\/strong>: \u201cAs founding partners of Gavi, the pharmaceutical industry is proud of its collaboration to combat infectious diseases, contain outbreaks, and tackle some of the biggest global health challenges for over two decades. We remain dedicated to accelerating the development, production, and equitable distribution of safe, effective, and affordable vaccines \u2013 protecting lives worldwide\u201d.
Emily Bensen, Chief Partnership Officer and Incoming CEO, Integrate Health: <\/strong>\u201cAt Integrate Health, we leverage private capital to turn big challenges into practical solutions for equitable healthcare delivery by testing innovations, costing them with rigor, and packaging results to inform government-led scale. This \u2018learning lab\u2019 approach is delivering results in Guinea, where thanks to Gavi Matching Fund investment over the past two years, 4,500 formerly zero-dose children are now vaccinated. Together, we\u2019re ready to accelerate impact across Guinea and into another West African country, scaling what works with fit-for-purpose digital tools and the introduction of the malaria vaccine.\u201d
Michael Anderson, CEO, MedAccess:<\/strong> \u201cMedAccess is pleased to join Gavi in a partnership to create new financial tools to support vaccine manufacturing in Africa. We share with Gavi and the African Union the aim of ensuring children can be protected by effective, regionally produced vaccines, with reliable supplies even in times of crisis.\u201d
Robert M. Davis, chairman and Chief Executive Officer, MSD: <\/strong>\u201cMSD has been a pioneer in the fight against vaccine-preventable diseases for over a century, and we are pleased to continue our long-standing collaboration with Gavi as a key supplier of HPV vaccines from 2026 to 2030. We remain committed to ensuring broad and sustainable access to our HPV vaccines in support of Gavi\u2019s ambitious goal to reach 120 million girls by 2030 \u2013 and through our investments in production capacity over the years, we have ample supply to meet the growing global demand. Together, we are working to protect some of the most vulnerable populations from HPV-related cancers and diseases, including cervical cancer worldwide.\u201d
Kitty Arie, CEO of Results UK: <\/strong>\u201cThe creation of Gavi stands as one of the most transformative global health innovations of our time, and its success over the past 25 years is best measured in the millions of lives saved. Civil society has played a vital role in delivering this achievement, as well as campaigning tirelessly to ensure global support for immunisation. In an era of constrained international development budgets, we commend the UK government for recognising Gavi\u2019s life-saving, country-led, and cost-effective approach. We look forward to continuing our support as Gavi innovates, deepens its collaboration with global health institutions, and ensures that countries, communities, and civil society remain at the heart of its mission.\u201d
Inger Ashing, Chief Executive Officer, Save the Children International: <\/strong>\u201cGavi is one of the most effective public health investments in modern history, helping immunise over a billion children in 25 years. Gavi ensures life-saving vaccines reach those who need them most strengthens pandemic preparedness and helps builds robust health systems. At Save the Children, we work with governments and communities \u2013 most recently in Malawi during the cholera outbreak \u2013 to protect children from deadly diseases. With partners, we are also reaching millions of zero-dose children in Nigeria and Ethiopia. None of this would be possible without Gavi making vaccines affordable and accessible for the most vulnerable. Continued funding for Gavi is essential \u2013 because vaccination makes all of us safer.\u201d
Toby Norman, CEO, Simprints: <\/strong>\u201cWe\u2019re thrilled to continue working with Gavi, Arm, and CIFF on this new venture, which will leverage biometrics powered by AI to help reach millions of children with life-saving vaccinations. Our mission at Simprints is to transform the way the world fights poverty and disease, and our ongoing partnership reflects a shared vision of every child, in every community, having access to life-saving vaccines.\u201d
Chika Kemi Offor, Chief Executive Officer, Vaccine Network for Disease Control (VNDC): <\/strong>\u201cI have always believed that vaccine is one of the greatest inventions known to man.For this miracle called vaccine to save more lives all hands must be on deck. We must all come together, provide the necessary funds so more lives can be saved \u2013 the ability to prevent is a powerful reminder that saving lives is possible. Let’s do this!\u201d
Dr Ahmed Ogwell Ouma, CEO and President, Village Reach<\/strong>: \u201cLow- and middle-income countries committing nearly half of the required vaccine financing is not only historic \u2013 but a powerful demonstration of leadership, accountability, and shared responsibility. At Village Reach, we believe that health systems resilience begins with countries investing in this course. The commitment to co-financing will not only strengthen immunization but anchor it within the broader primary healthcare systems, even in the most fragile and under-reached settings. We support and will continue to work with governments that are choosing to prioritize stronger health systems including vaccines because they understand what\u2019s at stake: the health and future of their children.\u201d
Ajay Banga, President, World Bank Group:<\/strong> \u201cBy expanding joint investments, our partnership with Gavi will help us reach our goal of delivering quality healthcare to 1.5 billion people by 2030. In pursuit of that goal, we will strengthen health systems, build manufacturing capacity, invest in skills, and ultimately create jobs in the health sector. The World Bank Group is proud to support Gavi\u2019s replenishment efforts and recognizes its vital role in bringing together public and private partners to advance this mission.\u201d
Keller Rinaudo, Co-founder, Zipline: <\/strong>\u201cAlmost ten years ago we teamed up with Gavi on a simple idea: create an automated logistics system so reliable that no child ever misses a dose, and vaccination gaps disappear. In the next few years, Gavi can light up this network across the continent, help ministries hit universal health care targets, and save millions every year.\u201d
Notes to Editors<\/strong>
*The total funding secured for Gavi 6.0 since the launch of Gavi\u2019s replenishment campaign in June 2024 includes:
About Gavi, the Vaccine Alliance<\/strong>
Gavi, the Vaccine Alliance is a public-private partnership that helps vaccinate more than half the world\u2019s children against some of the world\u2019s deadliest diseases. The Vaccine Alliance brings together developing country and donor governments, the World Health Organization, UNICEF, the World Bank, the vaccine industry, technical agencies, civil society, the Gates Foundation and other private sector partners. View the full list of donor governments and other leading organisations that fund Gavi\u2019s work here<\/a>.
Since its inception in 2000, Gavi has helped to immunise a whole generation \u2013 over 1.1 billion children \u2013 and prevented more than 18.8 million future deaths, helping to halve child mortality in 78 lower\u2011income countries. Gavi also plays a key role in improving global health security by supporting health systems as well as funding global stockpiles for Ebola, cholera, meningococcal and yellow fever vaccines. After two decades of progress, Gavi is now focused on protecting the next generation, above all the zero-dose children who have not received even a single vaccine shot. The Vaccine Alliance employs innovative finance and the latest technology \u2013 from drones to biometrics \u2013 to save lives, prevent outbreaks before they can spread and help countries on the road to self-sufficiency. Learn more at www.gavi.org<\/a> and connect with us on Facebook<\/a> and X (Twitter)<\/a>.
About Gates Foundation<\/strong>
Guided by the belief that every life has equal value, the Gates Foundation works to help all people lead healthy, productive lives. In developing countries, we work with partners to create impactful solutions so that people can take charge of their futures and achieve their full potential. In the United States, we aim to ensure that everyone\u2014especially those with the fewest resources\u2014has access to the opportunities needed to succeed in school and life. Based in Seattle, Washington, the foundation is led by CEO Mark Suzman, under the direction of Bill Gates and our governing board.
Portuguese<\/a> | Spanish<\/a>
Gavi<\/strong>
Meg Sharafudeen<\/strong>
+41 79 711 55 54
msharafudeen@gavi.org<\/a>
Cir\u0169 Kari\u0169ki<\/strong>
+41 79 913 94 41
ckariuki@gavi.org<\/a>
Gates Foundation<\/strong>
media@gatesfoundation.org<\/a>
+1 206-709-3400
European Commission<\/strong>
Arianna Podesta<\/strong>
arianna.podesta@ec.europa.eu<\/a>
+32 460 76 03 78<\/a>
Guillaume Mercier<\/strong>
guillaume.mercier@ec.europa.eu<\/a>
+32 460 75 53 11<\/a>
European Council<\/strong>
Beatriz Navarro<\/strong>
press.president@consilium.europa.eu<\/a>
+32 471 33 22 92
Carlo Zarcone<\/strong>
carlo.zarcone@consilium.europa.eu<\/a>
+32 471 33 31 73
\u00a9 Gavi 2025
Our achievements are thanks to the support and expertise of our founding partners<\/em>
<\/a><\/a><\/a><\/a><\/p>\n

source<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Contact us ISO certification Phishing & fraudContact us ISO certification Phishing & fraudAbout Gavi Facts & figures Contact usAbout Gavi Facts & figures Contact usStrategic financeAs part of our long-term funding and private sector engagement strategy, we use innovative finance mechanisms to incentivise investment in immunisation.Learn moreKey publication Gavi’s Investment Opportunity 2026\u20132030DownloadGlobal Summit, 25 June 2025Global […]<\/p>\n","protected":false},"author":1,"featured_media":157276,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_genesis_hide_title":false,"_genesis_hide_breadcrumbs":false,"_genesis_hide_singular_image":false,"_genesis_hide_footer_widgets":false,"_genesis_custom_body_class":"","_genesis_custom_post_class":"","_genesis_layout":"","footnotes":""},"categories":[10],"tags":[],"class_list":["post-157275","post","type-post","status-publish","format-standard","has-post-thumbnail","category-world","entry"],"_links":{"self":[{"href":"https:\/\/quixnet.net\/wpinstance\/wp-json\/wp\/v2\/posts\/157275","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/quixnet.net\/wpinstance\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/quixnet.net\/wpinstance\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/quixnet.net\/wpinstance\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/quixnet.net\/wpinstance\/wp-json\/wp\/v2\/comments?post=157275"}],"version-history":[{"count":0,"href":"https:\/\/quixnet.net\/wpinstance\/wp-json\/wp\/v2\/posts\/157275\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/quixnet.net\/wpinstance\/wp-json\/wp\/v2\/media\/157276"}],"wp:attachment":[{"href":"https:\/\/quixnet.net\/wpinstance\/wp-json\/wp\/v2\/media?parent=157275"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/quixnet.net\/wpinstance\/wp-json\/wp\/v2\/categories?post=157275"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/quixnet.net\/wpinstance\/wp-json\/wp\/v2\/tags?post=157275"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}